Martin Short is reminiscing about his time with the late Gilda Radner, shedding some rare light on their on-again, off-again ...

CERO), a micro-cap immunotherapy company with a market value of $2.61 million, announced preclinical findings of its lead compound CER-1236 for ovarian cancer at the 2025 SITC Spring Scientific ...

Amidst global market turbulence, Asian markets have shown resilience, with Japan's stock indices experiencing modest gains and China's markets buoyed by stimulus hopes. In such an environment, ...

Phase 3 Ovarian Cancer Trial to Initiate in March 2025 ... SUBSCRIBE TO ZACKS SMALL CAP RESEARCH to receive our articles and reports emailed directly to you each morning. Please visit our website ...

Kiwi deputy principal Nick Edwards was moved to fundraise for Ovarian Cancer New Zealand after ... goggles and a swim cap, to fulfil marathon swimming rules. This also means he cannot have ...

There were only four harness races on the dual code card at Wingatui today and female drivers wearing Team Teal ...

We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a ...

Headquartered in Fort Myers, FL, NeoGenomics operates a network of CAP-accredited and CLIA-certified laboratories ... Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer ...

Verastem's assets, Avutometinib and Defactinib, show promising results in treating KRAS-mutated LGSOC. Read why VSTM stock is a Hold.

Fulgent Genetics has a low Price/Book ratio and promising drug candidates. Key trial results are expected in May 2025. Read ...

We recently published an article titled Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025. In this article, we are going to take a look at where Genelux Corporation (NASDAQ:GNLX) stands ...